Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

Clinical trial NCT00485459 · COMPLETED

Trial details

NCT number: NCT00485459
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2004-02-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.